Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations

Author： Williams Hywel   Sassene Philip   Kleberg Karen   Calderone Marilyn   Igonin Annabel   Jule Eduardo   Vertommen Jan   Blundell Ross   Benameur Hassan   Müllertz Anette   Pouton Colin   Porter Christopher  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.30, Iss.12, 2013-12, pp. : 3059-3076

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life

By Arnold Yvonne E.   Imanidis Georgios   Kuentz Martin  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 10, 2012-10 ,pp. : 1262-1269

Informa Healthcare

Access to resources Recommend Favorite

Characteristics and evaluation of an injectable clarithromycin lipid-based complex in vitro and in vivo

By Ma Yan   Li HaiGang   Guan ShiXia  

Drug Delivery, Vol. 20, Iss. 8, 2013-11 ,pp. : 349-355

Informa Healthcare

Access to resources Recommend Favorite

Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling

By Stillhart Cordula   Imanidis Georgios   Kuentz Martin  

Pharmaceutical Research, Vol. 30, Iss. 12, 2013-12 ,pp. : 3114-3130

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro Lipolysis and Intestinal Transport of β-Arteether-Loaded Lipid-Based Drug Delivery Systems

By Memvanga Patrick   Eloy Pierre   Gaigneaux Eric   Préat Véronique  

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2694-2705

Springer Publishing Company

Access to resources Recommend Favorite

Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo

By Rudolph Carsten   Schillinger Ulrike   Ortiz Aurora   Tabatt Kerstin   Plank Christian   Müller Rainer H.   Rosenecker Joseph  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1662-1669

Springer Publishing Company

Access to resources Recommend Favorite